Загрузка...
EFFECTS OF SODIUM THIOSULFATE VERSUS OBSERVATION ON DEVELOPMENT OF CISPLATIN-INDUCED HEARING LOSS IN CHILDREN WITH CANCER: RESULTS FROM THE CHILDREN’S ONCOLOGY GROUP ACCL0431 RANDOMISED CLINICAL TRIAL
BACKGROUND: Sodium thiosulfate (STS) is an antioxidant shown in preclinical studies to prevent cisplatin-induced hearing loss (CIHL) but not compromise anti-tumour efficacy with timed administration post-cisplatin. The primary study aim was to evaluate STS for prevention of CIHL. METHODS: ACCL0431 w...
Сохранить в:
| Опубликовано в: : | Lancet Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520988/ https://ncbi.nlm.nih.gov/pubmed/27914822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30625-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|